Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel Hladun

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Targeted Oncology|December 12, 2022
Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with NeuroblastomaJulia Balaguer, Laura García Hidalgo, Raquel Hladun, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|September 21, 2021
[Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours]Federico Rojo, Ramón Colomer, Fernando López-Ríos, et al.
Medicina Clinica|July 14, 2018
Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON)Laura Alonso, Marta González-Vicent, Cristina Belendez, et al.
Pediatric Blood & Cancer|November 21, 2024
Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical TrialGianni Bisogno, Veronique Minard-Colin, Josephine Haduong, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2024
Recommendations for the use of nuclear medicine imaging in patients with neuroblastomaRaquel Sánchez-Vañó, Julia Balaguer, Isabel Borrego-Dorado, et al.
Experimental & Molecular Medicine|April 28, 2018
Targeting of epigenetic regulators in neuroblastomaLuz Jubierre, Carlos Jiménez, Eric Rovira, et al.
Cancers|February 11, 2023
Targeting the Hedgehog Pathway in RhabdomyosarcomaPatricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, et al.
International Journal of Molecular Sciences|December 10, 2021
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In VivoIrina Giralt, Gabriel Gallo-Oller, Natalia Navarro, et al.
Cancers|October 13, 2021
Neuronal Differentiation-Related Epigenetic Regulator <i>ZRF1</i> Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In VitroCarlos Jiménez, Roberta Antonelli, Marc Masanas, et al.
Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Targeted Oncology|December 12, 2022
Recent Evidence-Based Clinical Guide for the Use of Dinutuximab Beta in Pediatric Patients with NeuroblastomaJulia Balaguer, Laura García Hidalgo, Raquel Hladun, et al.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|September 21, 2021
[Multidisciplinary consensus on optimizing the detection of NTRK gene alterations in tumours]Federico Rojo, Ramón Colomer, Fernando López-Ríos, et al.
Medicina Clinica|July 14, 2018
Hematopoietic stem cell transplantation in pediatric patients with thalassemia and sickle cell disease: An experience of the Spanish Working Group for Bone Marrow Transplantation in Children (GETMON)Laura Alonso, Marta González-Vicent, Cristina Belendez, et al.
Pediatric Blood & Cancer|November 21, 2024
Implications of Implementing Children's Oncology Group Risk Stratification to Patients With Rhabdomyosarcoma Treated on European Paediatric Soft Tissue Sarcoma Study Group Clinical TrialGianni Bisogno, Veronique Minard-Colin, Josephine Haduong, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2024
Recommendations for the use of nuclear medicine imaging in patients with neuroblastomaRaquel Sánchez-Vañó, Julia Balaguer, Isabel Borrego-Dorado, et al.
Experimental & Molecular Medicine|April 28, 2018
Targeting of epigenetic regulators in neuroblastomaLuz Jubierre, Carlos Jiménez, Eric Rovira, et al.
Cancers|February 11, 2023
Targeting the Hedgehog Pathway in RhabdomyosarcomaPatricia Zarzosa, Lia Garcia-Gilabert, Raquel Hladun, et al.
International Journal of Molecular Sciences|December 10, 2021
Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In VivoIrina Giralt, Gabriel Gallo-Oller, Natalia Navarro, et al.
Cancers|October 13, 2021
Neuronal Differentiation-Related Epigenetic Regulator <i>ZRF1</i> Has Independent Prognostic Value in Neuroblastoma but Is Functionally Dispensable In VitroCarlos Jiménez, Roberta Antonelli, Marc Masanas, et al.
Journal of Neuro-Oncology|December 14, 2017
Outcome of children and adolescents with central nervous system tumors in phase I trialsFernando Carceller, Francisco Bautista, Irene Jiménez, et al.
Pageof 3